{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:21:04Z","timestamp":1791105664821,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1124\/mol.64.3.619","type":"journal-article","created":{"date-parts":[[2003,8,14]],"date-time":"2003-08-14T23:48:50Z","timestamp":1060904930000},"page":"619-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["L-DOPA Treatment Modulates Nicotinic Receptors in Monkey Striatum"],"prefix":"10.1016","volume":"64","author":[{"given":"Maryka","family":"Quik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuja","family":"Bordia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaella","family":"Okihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Whiteaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.64.3.619_bib1","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1523\/JNEUROSCI.19-15-06475.1999","article-title":"Ultrastructural localization of the alpha4subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra","volume":"19","author":"Arroyo-Jimenez","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/mol.64.3.619_bib2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.64.3.619_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","article-title":"Pathophysiology of levodopa-induced dyskinesia: potential for new therapies","volume":"2","author":"Bezard","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/mol.64.3.619_bib4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.22-04-01208.2002","article-title":"Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice","volume":"22","author":"Champtiaux","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/mol.64.3.619_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0003-2697(74)90265-6","article-title":"A new rapid assay for measuring deoxycytidylate- and deoxythymidylate-kinase activities","volume":"60","author":"Cheng","year":"1974","journal-title":"Anal Biochem"},{"key":"10.1124\/mol.64.3.619_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0006-8993(85)90456-1","article-title":"Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons","volume":"348","author":"Clarke","year":"1985","journal-title":"Brain Res"},{"key":"10.1124\/mol.64.3.619_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3565(25)22727-6","article-title":"Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion","volume":"271","author":"Collins","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.64.3.619_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0306-4522(00)00071-3","article-title":"Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson\u2019s disease and Alzheimer\u2019s disease and in relation to neuroleptic medication","volume":"98","author":"Court","year":"2000","journal-title":"Neuroscience"},{"key":"10.1124\/mol.64.3.619_bib9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-3565(25)20388-3","article-title":"Presynaptic facilitation of dopamine release through D,L-alpha-amino-3- hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum","volume":"259","author":"Desce","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.64.3.619_bib10","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1124\/mol.64.3.619_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0026-895X(25)08832-7","article-title":"A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment","volume":"41","author":"Flores","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.64.3.619_bib12","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1471-1931(00)00019-7","article-title":"Molecular effects of dopamine on striatal-projection pathways","volume":"23","author":"Gerfen","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.64.3.619_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2001.00019.x","article-title":"Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum","volume":"76","author":"Grady","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/mol.64.3.619_bib14","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1046\/j.1460-9568.2000.00262.x","article-title":"Localization of nAChR subunit mRNAs in the brain of Macaca mulatta","volume":"12","author":"Han","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.64.3.619_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/cne.1345","article-title":"Presynaptic localisation of the nicotinic acetylcholine receptor beta2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurones","volume":"439","author":"Jones","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1124\/mol.64.3.619_bib16","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1073\/pnas.86.22.9006","article-title":"Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus","volume":"86","author":"Kemel","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.64.3.619_bib17","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.21-05-01452.2001","article-title":"Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei","volume":"21","author":"Klink","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/mol.64.3.619_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/mol.61.1.230","article-title":"Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites","volume":"61","author":"Kulak","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.64.3.619_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.102.039347","article-title":"Declines in different \u03b22* containing nicotinic receptor populations in monkey striatum after nigrostriatal damage","volume":"303","author":"Kulak","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.64.3.619_bib20","first-page":"S79","article-title":"Investigating levodopa-induced dyskinesias in the parkinsonian primate","volume":"47","author":"Langston","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.64.3.619_bib21","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/j.1460-9568.1996.tb01206.x","article-title":"Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain","volume":"8","author":"Le Novere","year":"1996","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.64.3.619_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0031-6997(24)01406-6","article-title":"International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits","volume":"51","author":"Lukas","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.64.3.619_bib23","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1523\/JNEUROSCI.12-07-02765.1992","article-title":"Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment","volume":"12","author":"Marks","year":"1992","journal-title":"J Neurosci"},{"key":"10.1124\/mol.64.3.619_bib24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0026-895X(25)09534-3","article-title":"Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of l-3,4-dihydroxyphenylalanine","volume":"50","author":"Morissette","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.64.3.619_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0969-8051(98)00101-2","article-title":"Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon","volume":"26","author":"Musachio","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1124\/mol.64.3.619_bib26","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S1471-1931(00)00022-7","article-title":"Organization of the basal ganglia: the importance of axonal collateralization","volume":"23","author":"Parent","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.64.3.619_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1471-4159.2002.00951.x","article-title":"Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography","volume":"82","author":"Perry","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/mol.64.3.619_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X","article-title":"Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization","volume":"425","author":"Quik","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1124\/mol.64.3.619_bib29","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1523\/JNEUROSCI.21-15-05494.2001","article-title":"Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey","volume":"21","author":"Quik","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/mol.64.3.619_bib30","first-page":"1","article-title":"Nicotine and nicotinic receptors; relevance to Parkinson\u2019s disease","volume":"131","author":"Quik","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1124\/mol.64.3.619_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/mol.63.5.1169","article-title":"Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice","volume":"63","author":"Quik","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.64.3.619_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.870120204","article-title":"The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys","volume":"12","author":"Rioux","year":"1997","journal-title":"Mov Disord"},{"key":"10.1124\/mol.64.3.619_bib33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1471-4159.1979.tb11096.x","article-title":"Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions","volume":"32","author":"Roberts","year":"1979","journal-title":"J Neurochem"},{"key":"10.1124\/mol.64.3.619_bib34","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1471-4159.1990.tb05802.x","article-title":"Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes","volume":"55","author":"Rowell","year":"1990","journal-title":"J Neurochem"},{"key":"10.1124\/mol.64.3.619_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1471-4159.1985.tb04005.x","article-title":"In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs","volume":"45","author":"Schwartz","year":"1985","journal-title":"J Neurochem"},{"key":"10.1124\/mol.64.3.619_bib36","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1471-4159.1984.tb02818.x","article-title":"Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain","volume":"42","author":"Schwartz","year":"1984","journal-title":"J Neurochem"},{"key":"10.1124\/mol.64.3.619_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.bjp.0703616","article-title":"Identification of a novel nicotinic binding site in mouse brain using [125I]-epibatidine","volume":"131","author":"Whiteaker","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.64.3.619_bib38","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.22-07-02522.2002","article-title":"Involvement of the alpha3 subunit in central nicotinic binding populations","volume":"22","author":"Whiteaker","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/mol.64.3.619_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0166-2236(96)10073-4","article-title":"Presynaptic nicotinic ACh receptors","volume":"20","author":"Wonnacott","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.64.3.619_bib40","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nn769","article-title":"Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum","volume":"4","author":"Zhou","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1124\/mol.64.3.619_bib41","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J Neurosci"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24055949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24055949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.64.3.619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:45:50Z","timestamp":1740041150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24055949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S0026895X24055949"],"URL":"https:\/\/doi.org\/10.1124\/mol.64.3.619","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L-DOPA Treatment Modulates Nicotinic Receptors in Monkey Striatum","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.64.3.619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}